These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 34731778)
1. How Early in Life do Transgender Adults Begin to Experience Gender Dysphoria? Why This Matters for Patients, Providers, and for Our Healthcare System. Zaliznyak M; Yuan N; Bresee C; Freedman A; Garcia MM Sex Med; 2021 Dec; 9(6):100448. PubMed ID: 34731778 [TBL] [Abstract][Full Text] [Related]
2. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services. Zaliznyak M; Jung EE; Bresee C; Garcia MM J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448 [TBL] [Abstract][Full Text] [Related]
3. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study. Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Factors Associated With Gender-Affirming Surgery Among Transgender Women & Transgender Men in a Community-Based Clinic in Metro Manila, Philippines: A Retrospective Study. Eustaquio PC; Castelo AV; Araña YS; Corciega JOL; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES Sex Med; 2022 Apr; 10(2):100497. PubMed ID: 35247792 [TBL] [Abstract][Full Text] [Related]
5. Is size in the eye of the beholder? Visual estimation of penis size among transgender and cisgender people and implications for genital gender-affirming surgery and sexual medicine. Castaneda PR; Zaliznyak M; Sandhu SS; Cook-Wiens G; Smith SM; Mallavarapu S; Garcia MM J Sex Med; 2024 Jan; 21(2):175-180. PubMed ID: 38112322 [TBL] [Abstract][Full Text] [Related]
6. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence. Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926 [TBL] [Abstract][Full Text] [Related]
7. [Transgender and Gender Dysphoria: Viewpoints on Clinical Care and Psychological Stress]. Hsu CY Hu Li Za Zhi; 2023 Feb; 70(1):17-22. PubMed ID: 36647306 [TBL] [Abstract][Full Text] [Related]
8. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy. Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383 [No Abstract] [Full Text] [Related]
9. The Epidemiology of Gender Dysphoria in Iran: The First Nationwide Study. Talaei A; Hedjazi A; Badieyan Moosavi N; Dadgarmoghaddam M; Lotfinejad N; Khorashad BS Arch Sex Behav; 2022 May; 51(4):1881-1889. PubMed ID: 35511409 [TBL] [Abstract][Full Text] [Related]
11. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study. Rutnin S; Suchonwanit P; Kositkuljorn C; Pomsoong C; Korpaisarn S; Arunakul J; Rattananukrom T Transgend Health; 2023 Feb; 8(1):89-99. PubMed ID: 36824384 [TBL] [Abstract][Full Text] [Related]
12. Effects of Gender-affirming Hormone Therapy on Orgasm Function of Transgender Men and Women: A Long Term Follow Up. Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM Urology; 2023 Apr; 174():86-91. PubMed ID: 36646176 [TBL] [Abstract][Full Text] [Related]
13. Genital Gender-Affirming Surgery Without Urethral Lengthening in Transgender Men-A Clinical Follow-Up Study on the Surgical and Urological Outcomes and Patient Satisfaction. Pigot GLS; Al-Tamimi M; Nieuwenhuijzen JA; van der Sluis WB; Moorselaar RJAV; Mullender MG; van de Grift TC; Bouman MB J Sex Med; 2020 Dec; 17(12):2478-2487. PubMed ID: 33071204 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy. Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824 [TBL] [Abstract][Full Text] [Related]
15. Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study. Castellini G; Rossi E; Cassioli E; Sanfilippo G; Ristori J; Vignozzi L; Maggi M; Ricca V; Fisher AD J Sex Med; 2023 Feb; 20(3):388-397. PubMed ID: 36763949 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals. Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185 [TBL] [Abstract][Full Text] [Related]
17. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand. Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a transgender population in Portugal. Ferreira MJ; Castedo JL; Mota M; Carvalho D Ann Endocrinol (Paris); 2022 Feb; 83(1):35-39. PubMed ID: 34871600 [TBL] [Abstract][Full Text] [Related]
19. Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals. Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandić M; Brismar TB; Dahlqvist Leinhard O; Chanpen S; Flanagan JN; Arver S; Gustafsson T J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31794605 [TBL] [Abstract][Full Text] [Related]